Vivus Inks 11th-Hour Compromise To Avoid Proxy Fight
A heated, monthslong proxy battle between Vivus Inc. and its largest shareholder ended in a compromise Friday, with the drugmaker agreeing to expand its board and allow activist investor First Manhattan...To view the full article, register now.
Already a subscriber? Click here to view full article